Archive for July 2013

Following the formation of the pharmaceutical Pradaxa multidistrict litigation (MDL 2385) in late 2012, there have been more than 640 new federal claims filed. The majority of plaintiffs are alleging that the blood thinner has caused them internal bleeding and other potentially life-threatening side effects. Dabigatran, better known as Pradaxa, marketed by Boehringer Ingelheim, is…